DUBLIN, Oct. 24 -- The Ireland Department of Jobs, Enterprise and Innovation issued the following news release:
TheMinister for Jobs, Enterprise and Innovation, Richard Bruton TD, together with the Minister for Research & Innovation, Sean Sherlock TD, today (Thursday) launched the Advanced Materials and Bio-Engineering Research Centre (AMBER).
The Centre is funded by the Department of Jobs, Enterprise and Innovation through Science Foundation Ireland (SFI) in the amount of EUR35million. This funding is leveraged with an additional EUR23million from 18 industry partners.
AMBER will work to translate science into new discoveries and devices for a range of sectors, particularly ICT, medical devices and industrial technologies.
Speaking at the launch, Minister Bruton said: "Almost 50% of IDA jobs wins are connected to SFI research projects - that's almost 6000 jobs per year over recent years. Therefore, if we are to achieve the level of job-creation we need, we must ensure that our science and research spending is properly targeted at employment opportunities. As part of the Action Plan for Jobs we are making a series of changes to achieve this, including the new SFI centres programme which will focus our spending in this area on 7 large-scale research centres which can attract industry funding and compete with the best in the world.
"The establishment of AMBER is a key part of this plan. Nanoscience and materials science are areas where we rank well inside the top ten internationally for research. The scale and ambition of this centre means that we can attract 18 industry partners and leading international researchers who can turn these good ideas into good jobs. I commend all involved and wish them every success with this crucial project".
Minister Sherlock stated that, "With nanoscience linked to EUR15 billion or 10% of Irish exports and 250,000 jobs in sectors like technology, biomedicine, pharmaceuticals, energy and more, the importance of AMBER as a driver of future materials science research is clear. As a national centre, AMBER will play a key role in growing and retaining existing companies, providing world-leading research, increasing the level of foreign direct investment and enabling job creation in Ireland."
AMBER is an academia-industry research consortium dedicated to developing new materials and medical devices which includes the development of novel silicon and magnetic memory devices which will impact communication devices like mobile phones; medical implant coatings which will improve patient care, for example hip implants and other products such as thermoelectric devices.
The AMBER Research Centre is led by Trinity College Dublin in collaboration with University College Cork and the Royal College of Surgeons of Ireland. AMBER will directly support 99 jobs and there is potential for further job creation.
Professor Stefano Sanvito, AMBER said, "AMBER will strengthen Ireland's reputation for research, create new intellectual property; and support industrial collaborations and the commercialisation of research. The Centre will work to educate the next generation of researchers and create breakthroughs that influence everyone's quality of life; such as the development of next generation computer chips; new medical devices, implants and pharmaceuticals which will improve patient care."
"The AMBER Centre will deliver world-leading research into engineered materials and interfaces for applications in a number of priority sectors in Ireland, most notably in ICT, medical devices, and industrial technology. By delivering research of global quality, AMBER will support the development of advanced manufacturing in Ireland, and they will work with industry to attract additional foreign direct investment, thus supporting a research mandate for Irish-based companies."
Professor Mark Ferguson, Director General of SFI said, "The SFI Research Centres Programme represents the largest ever state industry co-funded research investment of its kind in Ireland. The programme will see EUR200 million of Irish exchequer funding matched by EUR100 million in support from industry invested in seven world class research centres of scale, one of which is AMBER. AMBER has the potential to impact positively on Ireland's future, not only in terms of the research outputs and resulting economic gain, but also in terms of creating and maintaining a strong pool of excellent talent within our shores. The foundation of AMBER has already delivered tangible economic benefits that include productive engagement with industry collaborators and the creation of new jobs."
Welcoming the announcement, Dr Patrick Prendergast, Provost of Trinity, said: 'The launch demonstrates the commitment of SFI, Government and industry to establish a leading international position for Ireland in materials science and to create high-quality, high-tech employment opportunities for the future. The link between industry and academia is a successful model and it ensures that the economic return of research is fully realised. Trinity is committed to driving a culture of job creation, and the close links between industry and academia which AMBER will forge could help to surface new business opportunities.'
AMBER (The Advanced Materials and Bioengineering Research Centre) is a collaboration of both researchers and industry representatives, which will develop new materials for use in ICT, medical device, energy and pharmaceuticals manufacturing. AMBER will be the primary authority for academics, industry partners and other stakeholders interested in collaborative research around new materials and medical device.
AMBER will carry out research in broad areas: Development of enhanced nanoscale electronic devices for data processing and memory applications; new materials to support innovation in medical devices and delivery systems, implants based on novel therapies, and regenerative tissue engineering; novel materials and processing for new products in areas such as the bottling industry, solar energy, medical devices, medical diagnostics and chemical and biological filtration and novel formulations and packaging to improve the distribution of pharmaceuticals.
CC AutoTriage1pm-131025-30TagarumaMar-4527501 30TagarumaMar